X-154477961-G-T
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 0P and 5B. BP4BS2
The NM_006014.5(LAGE3):c.415C>A(p.Pro139Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000909 in 1,209,884 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 2 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 12/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_006014.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -5 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LAGE3 | NM_006014.5 | c.415C>A | p.Pro139Thr | missense_variant | 3/3 | ENST00000357360.5 | NP_006005.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LAGE3 | ENST00000357360.5 | c.415C>A | p.Pro139Thr | missense_variant | 3/3 | 1 | NM_006014.5 | ENSP00000349923.4 |
Frequencies
GnomAD3 genomes AF: 0.0000177 AC: 2AN: 112853Hom.: 0 Cov.: 24 AF XY: 0.00 AC XY: 0AN XY: 35001
GnomAD3 exomes AF: 0.0000328 AC: 6AN: 182877Hom.: 0 AF XY: 0.0000148 AC XY: 1AN XY: 67499
GnomAD4 exome AF: 0.00000820 AC: 9AN: 1097031Hom.: 0 Cov.: 30 AF XY: 0.00000552 AC XY: 2AN XY: 362437
GnomAD4 genome AF: 0.0000177 AC: 2AN: 112853Hom.: 0 Cov.: 24 AF XY: 0.00 AC XY: 0AN XY: 35001
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 03, 2024 | The c.415C>A (p.P139T) alteration is located in exon 3 (coding exon 3) of the LAGE3 gene. This alteration results from a C to A substitution at nucleotide position 415, causing the proline (P) at amino acid position 139 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Aug 24, 2022 | This sequence change replaces proline, which is neutral and non-polar, with threonine, which is neutral and polar, at codon 139 of the LAGE3 protein (p.Pro139Thr). This variant is present in population databases (rs185059986, gnomAD 0.02%). This variant has not been reported in the literature in individuals affected with LAGE3-related conditions. Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0". The threonine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at